ARTICLE | Company News
BioChem receives marketing approval
March 9, 2000 8:00 AM UTC
BCHE received FDA marketing approval for its Pacis Bacillus Calmette-Guerin (BCG) live immunotherapy for carcinoma in situ of the bladder. BCHE will manufacture Pacis, and UroCor (UCOR) will distribut...